Pathogenic variants specific for MDS‐type myeloid neoplasms were found by NGS in the NRAS, U2AF1 and ZRSR2 genes with VAFs of 40%, 24% and 6%, respectively. The gene discussed is ZRSR2; the disease is myelodysplastic syndrome.